SinoVac was the only company that conducted phase 1 vaccine trial for the SARS-Cov-1 outbreak in 2002-2003. For SARS-Cov-1 and MERS, vaccines were not developed as the pandemic stopped of their own. After the emergence of SARS-Cov-2, a more lethal strain, researchers turned to data they accumulated for previous virus SARS-Cov-1 and MERS (Middle East Respiratory Syndrome) to develop vaccines. Critically ill patients are being kept on ventilators and in intensive care units (ICU) and treatment is being given case by case to save the lives from COVID-19. Till now treatment using anti-flu Avigan, remdesivir, dexamethasone, asthma steroid inhalant ciclesonide have been employed. Testing, treatment, isolation, quarantine, wearing face mask, social or physical distancing, and sanitization are the methods and tools being used so far to contain the pandemic. Some countries are more successful and others are less in keeping people healthy and economic activities rolling. All over the world governments, doctors, health care works, and other administrative staff are controlling the pandemic by employing a number of methods and techniques. Easing the lockdown is necessary to keep work and social life in place until a proper workable vaccine is developed. The lockdown and easing have been in rotation to slow down the spread of the virus. The data and results presented in this article are very important and useful in containing, treating, and eliminating the pandemic COVID-19.Īs of August 10, 2020, a total number of COVID-19 cases reached 20,002,577 and 733,842 deaths were recorded since the airborne outbreak occurred. Apart from vaccine preparation and availability, we provided data for therapy and treatment for COVID-19 and transmission and stability aspect of COVID-19 SARS-Cov-2 virus. in phase 2 trial on 508 volunteers found a satisfactory immune response to COVID-19 virus. has prepared a vaccine “CoronaVac” and inoculating volunteers in Indonesia and Brazil. Hundreds of thousand volunteers have registered already for vaccination in US and other parts of the world. Moderna Therapeutics conducting vaccine trial on 30 thousands volunteers, results will be known soon. By early next year, two billions of doses will be ready of Novavax. In September, Novavax Inc.’s vaccine will be ready for phase 3 trial. Oxford University-AstraZeneca vaccine is also under phase 3 trial in US, Brazil, and India. mRNA based vaccine of Pfizer-BioNTech after passing phase 2 trial is ready for testing on thousands of volunteers. Mass production of vaccine Sputnik V is underway at different locations to inoculate population in Russia, Philippines, Vietnam, Brazil, Saudi Arab, and United Arab Emirates (UAE), and India. Choose products in different sizes, formats and languages.A number of companies have announced the vaccines for COVID-19 pandemic that has caused extreme poverty, famine, and more than a billion people have lost livelihood all across the globe. This season’s flu materials include messaging to address flu recommendations. Print Materials: Flu-fighting posters for your school, office or business (Spanish, too!).Influenza (Flu) and Other Respiratory Diseases, California Department of Public Health.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |